期刊文献+

人CD40L真核表达载体构建及其在NIH3T3细胞膜上的表达

Construction of eukaryotic expression vector with gene of human CD40L and its expression in plasma membrane of NIH3T3
下载PDF
导出
摘要 目的:扩增人CD40L基因并在细胞膜上表达,建立一种不需蛋白纯化获得人CD40L的简单方法,为进一步研究其在肿瘤治疗中的作用及机制奠定基础.方法:利用梯度RT-PCR从Jurkat细胞中扩增CD40L基因,测序证明序列正确后构建pcDNA3.1-40L真核表达载体,转染NIH3T3细胞,流式细胞仪检测目的基因的表达.结果:从Jurkat细胞内成功扩增人CD40L基因,筛选到一个序列无误的克隆;成功构建pcDNA3.1-40L真核表达载体;经转染NIH3T3细胞和G418初步筛选,流式细胞检测证明约41%的NIH3T3细胞膜上有CD40L基因表达.结论:利用RT-PCR技术可以从Jurkat细胞内扩增CD40L基因,利用pcDNA3.1表达载体可以实现人CD40L基因在NIH3T3细胞膜上的表达. AIM: To amplify and express human CD40L gene in the plasma membrane of NIH3T3 for an easy and effective method to produce human CD40L protein. METHODS: Human CD40L gene was amplified by gradient RT-PCR from Jurkat cell line and subcloned into the T vector. After sequencing, pcDNA3.1- CD40L was constructed and transfected into NIH3T3 cell line. The expression of CD40L was tested by FACS. RESULTS: The CD40L gene was successfully amplified from Jurkat cell line. Sequencing identified a clone with CD40L gene without any mutation. After transfection into NIH3T3 and primary selection with G418, about 41% cells successfully transported the expressed CD40L protein to the plasma membrane. CONCLUSION: Human CD40L gene can be amplified from Jurkat cell line. pcDNA3.1 vector expresses CD40L successfully in NIH3T3 cell line and the expressed protein is partially transported to plasma membrane.
出处 《第四军医大学学报》 北大核心 2009年第14期1266-1269,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金(30571697) 河南省艾滋病科技攻关项目(2006037) 河南省医学科技攻关项目(200803085)
关键词 CD40配体 逆转录聚合酶链反应 pcDNA3.1-CD40L构建 NIH3T3 流式细胞术 CD40 ligand reverse transcriptase polymerase chainreaction construction of pcDNA3.1-CD40L NIH3T3 flow cytometry
  • 相关文献

参考文献10

  • 1Ganchat JF,Aubry JP,Mazzei G,et al.Human CD40-ligand:molecular cloning,cellular distribution and regulation of expression by factors controlling IgE production[J].FEBS Lett,1993,315 (3):259-266.
  • 2Bonehill A,Tuyaerts S,Van Nuffel AM,et al.Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L,CDT0 and Constitutively Active TLR4 Encoding mRNA[J].Mol Ther,2008,16(6):1170-1180.
  • 3Lefrancois L,Altman JD,Williams K,et al.Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells[J].J Immunol,2000,164:725-732.
  • 4von Euler H,Sadeghi A,Carlsson B,et al.Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma[J].J Immunother,2008,31(4):377-384.
  • 5Tong AW,Stone MJ.Prospects for CD40-directed experimental therapy of human cancer[J].Cancer Gene Ther,2003,10 (1):1-13.
  • 6Yan JC,Liu PJ,Du RZ,et al.Relationship between CD40 ligand expression and B type natriuretic peptide levels in patients with chronic heart failure[J].Clin Chim Acta,2008,392(1-2):17-20.
  • 7Natal C,Restituto P,Inigo C,et al.The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin[J].J Clin Endocrinol Metab,2008,93 (6):2319-2327.
  • 8Hou H,Obregon D,Len D,et al.Modulation of neuronal differentiation by CD40 isoforms[J].Biochem Biophys Res Commun,2008,369(2):641-647.
  • 9Quartier P,Sanal O,Bustamante J,et al.Clinical immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency[J].Clin Immunol,2004,110 (1):22-29.
  • 10Fanslow WC,Srinivasan S,Paxton R,et al.Structural characteristics of CD40 ligand that determine biological function[J].Semin Immunol,1994,6(5):267-278.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部